1. Home
  2. HALO vs NXE Comparison

HALO vs NXE Comparison

Compare HALO & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$68.77

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Logo Nexgen Energy Ltd.

NXE

Nexgen Energy Ltd.

HOLD

Current Price

$9.27

Market Cap

6.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HALO
NXE
Founded
1998
2011
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
6.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HALO
NXE
Price
$68.77
$9.27
Analyst Decision
Buy
Analyst Count
12
0
Target Price
$73.33
N/A
AVG Volume (30 Days)
2.3M
7.6M
Earning Date
11-03-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
56.68
N/A
EPS
4.74
N/A
Revenue
$1,242,852,000.00
N/A
Revenue This Year
$34.83
N/A
Revenue Next Year
$24.84
N/A
P/E Ratio
$14.54
N/A
Revenue Growth
31.19
N/A
52 Week Low
$47.00
$3.91
52 Week High
$79.50
$9.99

Technical Indicators

Market Signals
Indicator
HALO
NXE
Relative Strength Index (RSI) 58.75 54.80
Support Level $61.23 $8.14
Resistance Level $69.28 $9.66
Average True Range (ATR) 1.69 0.44
MACD 0.69 0.03
Stochastic Oscillator 93.54 73.34

Price Performance

Historical Comparison
HALO
NXE

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About NXE Nexgen Energy Ltd.

NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.

Share on Social Networks: